Souhaitez-vous accéder aux communiqués récents ?

Hereby please find the Annual Report 2024/25 for the group of Coloplast A/S. Attachment 11_2025_Annual_Report_2024-25 ...

Frumvarp að fjárhagsáætlun Reykjavíkurborgar fyrir árið 2026 og fimm ára tímabilið til 2030 er lögð fram í borgarstjórn til fyrri umræðu í dag 4. nóvember 2025. Samantekinn fjárhagsáætlun A- og...

Coloplast A/S - Annual Report 2024/25 & Remuneration Report 2024/25 FY 2024/25 organic growth of 7% and EBIT margin1 of 28%. Reported revenue in DKK grew 3% to DKK 27,874 million.• Organic growth...

2024/25Årsregnskabsmeddelelse 1. oktober 2024 - 30. september 2025 Organisk vækst på 7% og en overskudsgrad1 på 28% i 4. kvartal. Den rapporterede omsætning i danske kroner steg 0%,...

2024/25Full year financial results 1 October 2024 - 30 September 2025 Coloplast delivered Q4 organic growth of 7% and an EBIT margin1 of 28%. Reported revenue in DKK grew 0% with negative impact...

Juhtkonna kommentaar 2024/2025. majandusaasta oli PRFoodsile oluline ja pöördeline periood, mida iseloomustas ettevõtte finantsseisundi stabiliseerimine. Edukas võlakohustuste restruktureerimine...

Management Commentary The 2024/2025 financial year was a significant and transformative period for PRFoods, marked by the stabilisation of the company’s financial position. The successful...

2025 m. spalio 31 d. visuotinis AB Akola group akcininkų susirinkimas patvirtino AB Akola group konsoliduotąsias ir Bendrovės finansines ataskaitas, konsoliduotąją vadovybės ataskaitą, nepriklausomo...

On 31 October 2025 the Annual General Meeting of Shareholders of AB Akola Group approved the consolidated and the Company’s Financial Statements, consolidated Management Report, the Independent...

Dairy Council of California’s 2024–2025 Annual Report highlights innovation, collaboration and impact supporting dairy nutrition and public health.